consent
发表于 2025-3-23 09:59:51
Q&A of DMPK Issues and Tools for Drug Discovery,This section addresses some typical DMPK questions that an ADME scientist encounters during drug discovery support. These questions are addressed by means of general concepts, experimental approaches, and examples. They are also linked to other sections for the ease of search and understanding.
ALOFT
发表于 2025-3-23 14:10:10
Regulatory Documents for IND to Support FIH,This chapter is used as a reference for provided various resources as it comes to regulatory authorities. This includes the counties, codes of US federal regulations, IND sections plus various modules and notable guidance for industry by FDA.
avarice
发表于 2025-3-23 18:14:43
http://reply.papertrans.cn/29/2811/281039/281039_13.png
CYN
发表于 2025-3-24 01:53:33
http://reply.papertrans.cn/29/2811/281039/281039_14.png
STENT
发表于 2025-3-24 04:36:09
Cross-border-Unternehmensakquisitionen optimization of molecules based on key ADME attributes. This has had a huge impact on the molecular design cycles: design, synthesis, assessment and re-design..In this chapter, we discuss the strategies for optimization of small molecules during drug discovery and address various ADME liabilities t
自由职业者
发表于 2025-3-24 08:00:46
http://reply.papertrans.cn/29/2811/281039/281039_16.png
四指套
发表于 2025-3-24 13:25:11
http://reply.papertrans.cn/29/2811/281039/281039_17.png
Anthem
发表于 2025-3-24 15:32:22
Book 2022dicinal chemistry, pharmacology, drug metabolism and pharmacokinetics, bioanalysis, clinical sciences, biochemistry, pharmaceutics, and toxicology. It provides, for the first time, a completely integrated look at multiple aspects of ADME sciences (absorption, distribution, metabolism, and excretion
Haphazard
发表于 2025-3-24 19:39:53
http://reply.papertrans.cn/29/2811/281039/281039_19.png
chlorosis
发表于 2025-3-25 01:37:57
http://reply.papertrans.cn/29/2811/281039/281039_20.png